First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry


Droz J., Efstathiou E., Yildirim A., Cabrera P., Kim C. S. , Horchani A., ...Daha Fazla

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, cilt.34, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 34 Konu: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.urolonc.2015.12.005
  • Dergi Adı: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Özet

Aims: To compare the efficacy and tolerability of taxane and nontaxane therapy in senior adults with chemonaive metastatic castration resistant prostate cancer (mCRPC), and examine the effect of patient health status on outcomes.